NCT04016259

Brief Summary

The purpose of this study is to determine the feasibility, safety, and preliminary efficacy of a two-week self Cranial Electrical Stimulation(CES) on pain in older adults with knee osteoarthritis(OA)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 11, 2019

Completed
21 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 21, 2019

Completed
12 months until next milestone

Results Posted

Study results publicly available

November 16, 2020

Completed
Last Updated

November 16, 2020

Status Verified

October 1, 2020

Enrollment Period

4 months

First QC Date

July 9, 2019

Results QC Date

October 21, 2020

Last Update Submit

October 21, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Clinical Pain as Assessed by a Numeric Rating Scale (NRS) for Pain

    The NRS total score ranges from 0 (no pain) to 100 (most intense pain imaginable).

    week 2

  • Clinical Pain as Assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    The WOMAC ranges from 0 to 96, with higher scores indicating worse osteoarthritis (OA) pain-related symptoms

    week 2

Secondary Outcomes (13)

  • Experimental Pain Sensitivity as Measured Using a Multimodal Quantitative Sensory Testing (QST) Battery - Heat Pain Threshold (HPTH)

    week 2

  • Experimental Pain Sensitivity as Measured Using a Multimodal Quantitative Sensory Testing (QST) Battery - Heat Pain Tolerance (HPTO)

    week 2

  • Experimental Pain Sensitivity as Measured Using a Multimodal Quantitative Sensory Testing (QST) Battery - Pressure Pain Threshold (PPT)

    week 2

  • Experimental Pain Sensitivity as Measured Using a Multimodal Quantitative Sensory Testing (QST) Battery - Conditioned Pain Modulation (CPM)

    week 2

  • Psychosocial Symptoms as Measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety Short Form

    week 2

  • +8 more secondary outcomes

Study Arms (2)

Self-CES

EXPERIMENTAL
Device: Cranial Electrical Stimulation (CES)

Sham-CES

PLACEBO COMPARATOR
Device: Sham-CES

Interventions

CES will be applied for 60 minutes per session daily for 2 weeks (Monday to Friday) via the Alpha-Stim M Electromedical Products International, Inc., Mineral Wells, TX).

Also known as: Alpha-Stim M
Self-CES
Sham-CESDEVICE

For sham CES, the electrodes will be identical look and be placed in the same positions as for active stimulation, but the stimulator will not deliver electrical current.

Also known as: Alpha-Stim M
Sham-CES

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have self-reported unilateral or bilateral knee OA pain, according to American College of Rheumatology criteria
  • have had knee OA pain in the past 3 months with an average of at least 30 on a 100 Numeric Rating Scale (NRS) for pain
  • can speak and read English
  • have a device with internet access that can be used for secure video conferencing for real- time remote supervision
  • have no plan to change medication regimens for pain throughout the trial
  • are able to travel to the coordinating center
  • are willing and able to provide written informed consent prior to enrollment

You may not qualify if:

  • history of brain surgery, brain tumor, seizure,stroke, or intracranial metal implantation
  • serious medical illness, such as uncontrolled hypertension (i.e., systolic blood pressure/ diastolic blood pressure ≥ 150/95 mm Hg)heart failure, or history of acute myocardial infarction
  • alcohol/substance abuse
  • cognitive impairment
  • pregnancy or lactation
  • hospitalization within the preceding year for psychiatric illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Limitations and Caveats

Small sample size; limited demographic (older adults with knee OA) restricts generalizability; slight deviations among intervals between daily stimulation sessions (though, this may be consistent with real-world use); long term efficacy not evaluated

Results Point of Contact

Title
Hyochol "Brian" Ahn, PhD, RN, MSN, Associate Professor
Organization
The University of Texas Health Science Center at Houston

Study Officials

  • Hyochol Ahn, PhD, RN, MSN

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 9, 2019

First Posted

July 11, 2019

Study Start

August 1, 2019

Primary Completion

November 21, 2019

Study Completion

November 21, 2019

Last Updated

November 16, 2020

Results First Posted

November 16, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations